Claudio Saddy Rodrigues Coy
Overview
Explore the profile of Claudio Saddy Rodrigues Coy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
de Negreiros L, Pascoal L, Genaro L, Silva J, Rodrigues B, Camargo M, et al.
Am J Transl Res
. 2022 Aug;
14(7):4406-4425.
PMID: 35958439
Ulcerative colitis (UC) is a chronic intestinal inflammatory disease and familial adenomatous polyposis (FAP) is an autosomal dominant inherited disease. Both diseases, despite being different, may require the same surgical...
12.
Monaco-Ferreira D, Magro D, Coy C
Arq Gastroenterol
. 2022 Jul;
59(2):296-303.
PMID: 35830044
Background: The nutritional status of patients with colorectal cancer (CRC) impacts on treatment response and morbidity. An effective evaluation of the body composition includes the measurements of fat and visceral...
13.
Sassaki L, Magro D, Saad-Hossne R, Baima J, Flores C, Correia L, et al.
BMC Gastroenterol
. 2022 Jun;
22(1):268.
PMID: 35644668
Background: Anti-TNF therapy represented a landmark in medical treatment of ulcerative colitis (UC). There is lack of data on the efficacy and safety of these agents in Brazilian patients. The...
14.
Alves Jr A, Goto E, Pereira J, Domingues F, Avila M, Coy C, et al.
Arq Bras Cir Dig
. 2022 Feb;
34(4):e1639.
PMID: 35107501
Aim: The etiopathogenesis of disuse colitis (DC) has not yet been fully elucidated. The main theories consider that the disease may be related to an increase in anaerobic bacteria, the...
15.
Fucilini L, Genaro L, Sousa D, Coy C, Leal R, Ayrizono M
Arq Gastroenterol
. 2021 Dec;
58(4):483-490.
PMID: 34909854
Background: The increase in the incidence and prevalence rates of inflammatory bowel disease (IBD) is evident in many newly industrialized countries in Asia, Africa, Eastern Europe, and the American continent....
16.
Pozzuto L, Silveira M, Mendes M, Macedo L, Costa F, Martinez C, et al.
Front Oncol
. 2021 Dec;
11:762444.
PMID: 34858841
Body composition performed by computed tomography (CT) impacts on cancer patients' prognoses and responses to treatment. Myosteatosis has been related to overall survival (OS) and disease-specific survival in colorectal cancer...
17.
Quaresma A, Coy C, Damiao A, Kaplan G, Kotze P
Arq Gastroenterol
. 2019 Oct;
56(3):318-322.
PMID: 31633732
Background: The introduction of anti-TNF agents represented a landmark in the management of both Crohn's disease (CD) and ulcerative colitis (UC), with improved efficacy and safety when compared with conventional...
18.
Magro D, Santos A, Guadagnini D, de Godoy F, Silva S, Lemos W, et al.
Sci Rep
. 2019 Sep;
9(1):13263.
PMID: 31520001
Previous studies have demonstrated that patients with Crohn's disease (CD) in remission do not exhibit an improvement in gut microbiota composition, which might trigger relapses. The present study investigated the...
19.
Acciari A, Leal R, Coy C, Dias C, Ayrizono M
Arq Gastroenterol
. 2019 Aug;
56(2):131-140.
PMID: 31460575
Background: Crohn's disease is chronic, requires prolonged treatment, affects the physical and psychosocial health of patients and may alter their routine, quality of life and well-being. Recent studies recommend monitoring...
20.
de Castro M, Corona L, Pascoal L, Rodrigues B, Ayrizono M, Coy C, et al.
Clin Nutr ESPEN
. 2019 Aug;
33:60-65.
PMID: 31451278
Background And Aims: Crohn's disease is a chronic inflammatory disease consisting of alternated periods of relapse and remission. The disease is associated with altered body composition and micronutrient deficiencies. This...